ASPEN AEROGELS, INC. (ASPN) Spending and interest coverage
- R&D / revenue · 12 months: Value 5.55%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 3.76%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 5.55% | Research and development expense / revenue. Period ending 2026-06-30. $11.21M ÷ $202.09M × 100 ≈ 5.55% |
| Stock-based compensation / revenue · 12 months | 3.76% | Share-based compensation / revenue. Period ending 2026-06-30. $7.59M ÷ $202.09M × 100 ≈ 3.76% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 11.21M USD | Research and Development Expense |
| Revenue | 202.09M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 7.59M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -123.35M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $11.21M | $202.09M | $7.59M | $-123.35M | (m) | 5.55% | 3.76% | (m) | (m) |
| 2026-03-31 | $11.81M | $230.26M | $8.54M | $-99.72M | (m) | 5.13% | 3.71% | (m) | (m) |
| 2025-12-31 | $13.42M | $271.10M | $8.63M | $-378.23M | (m) | 4.95% | 3.18% | (m) | (m) |
| 2025-09-30 | $15.03M | $352.85M | (m) | $-293.13M | (m) | 4.26% | (m) | (m) | (m) |
| 2025-06-30 | $17.12M | $397.18M | (m) | $-272.38M | (m) | 4.31% | (m) | (m) | (m) |
| 2025-03-31 | $17.89M | $436.92M | (m) | $-247.24M | (m) | 4.10% | (m) | (m) | (m) |
| 2024-12-31 | $18.05M | $452.70M | (m) | $54.53M | (m) | 3.99% | (m) | (m) | (m) |
| 2024-09-30 | $17.72M | $413.83M | (m) | $41.20M | (m) | 4.28% | (m) | (m) | (m) |
| 2024-06-30 | $17.35M | $357.25M | (m) | $9.17M | (m) | 4.86% | (m) | (m) | (m) |
| 2024-03-31 | $16.75M | $287.63M | (m) | $-27.86M | (m) | 5.82% | (m) | (m) | (m) |
| 2023-12-31 | $16.36M | $238.72M | (m) | $-49.20M | (m) | 6.85% | (m) | (m) | (m) |
| 2023-09-30 | $16.48M | $214.11M | (m) | $-60.25M | (m) | 7.70% | (m) | (m) | (m) |
| 2023-06-30 | $16.95M | $190.06M | (m) | $-73.93M | (m) | 8.92% | (m) | (m) | (m) |
| 2023-03-31 | $17.44M | $187.54M | (m) | $-79.53M | (m) | 9.30% | (m) | (m) | (m) |
| 2022-12-31 | $16.93M | $180.36M | (m) | $-79.25M | (m) | 9.39% | (m) | (m) | (m) |
| 2022-09-30 | $16.05M | $152.23M | (m) | $-85.89M | (m) | 10.54% | (m) | (m) | (m) |
| 2022-06-30 | $14.43M | $145.90M | (m) | $-69.08M | (m) | 9.89% | (m) | (m) | (m) |
| 2022-03-31 | $12.59M | $131.93M | (m) | $-53.05M | (m) | 9.54% | (m) | (m) | (m) |
| 2021-12-31 | $11.44M | $121.62M | (m) | $-40.60M | (m) | 9.41% | (m) | (m) | (m) |
| 2021-09-30 | $10.42M | $113.17M | (m) | $-30.42M | (m) | 9.21% | (m) | (m) | (m) |
| 2021-06-30 | $9.43M | $106.98M | (m) | $-25.62M | (m) | 8.82% | (m) | (m) | (m) |
| 2021-03-31 | $8.94M | $99.95M | (m) | $-24.66M | (m) | 8.95% | (m) | (m) | (m) |
| 2020-12-31 | $8.73M | $100.27M | (m) | $-21.57M | (m) | 8.71% | (m) | (m) | (m) |
| 2020-09-30 | $9.00M | $123.76M | (m) | $-16.27M | (m) | 7.27% | (m) | (m) | (m) |
| 2020-06-30 | $8.96M | $134.99M | (m) | $-11.72M | (m) | 6.64% | (m) | (m) | (m) |
| 2020-03-31 | $8.71M | $139.88M | (m) | $-11.28M | (m) | 6.22% | (m) | (m) | (m) |
| 2019-12-31 | $8.41M | $139.38M | (m) | $-14.16M | (m) | 6.03% | (m) | (m) | (m) |
| 2019-09-30 | $7.53M | $128.55M | (m) | $-27.27M | (m) | 5.86% | (m) | (m) | (m) |
| 2019-06-30 | $6.87M | $117.06M | (m) | $-31.49M | (m) | 5.87% | (m) | (m) | (m) |
| 2019-03-31 | $6.64M | $109.20M | (m) | $-33.13M | (m) | 6.08% | (m) | (m) | (m) |
| 2018-12-31 | $6.32M | $104.36M | (m) | $-33.92M | (m) | 6.05% | (m) | (m) | (m) |
| 2018-09-30 | $6.05M | $105.04M | (m) | $-21.59M | (m) | 5.76% | (m) | (m) | (m) |
| 2018-06-30 | $6.14M | $108.31M | (m) | $-18.26M | (m) | 5.67% | (m) | (m) | (m) |
| 2018-03-31 | $6.21M | $111.70M | (m) | $-16.83M | (m) | 5.56% | (m) | (m) | (m) |
| 2017-12-31 | $6.18M | $111.63M | (m) | $-19.14M | (m) | 5.54% | (m) | (m) | (m) |
| 2017-09-30 | $6.13M | $102.91M | (m) | $-23.23M | (m) | 5.96% | (m) | (m) | (m) |
| 2017-06-30 | $6.00M | $105.27M | (m) | $-22.60M | (m) | 5.69% | (m) | (m) | (m) |
| 2017-03-31 | $5.57M | $107.92M | (m) | $-18.51M | (m) | 5.16% | (m) | (m) | (m) |
| 2016-12-31 | $5.31M | $117.74M | (m) | $-11.22M | (m) | 4.51% | (m) | (m) | (m) |
| 2016-09-30 | $5.18M | $127.48M | (m) | $-3.83M | (m) | 4.06% | (m) | (m) | (m) |
| 2016-06-30 | $4.99M | $129.46M | (m) | $-3.90M | (m) | 3.86% | (m) | (m) | (m) |
| 2016-03-31 | $5.26M | $131.84M | (m) | $-5.25M | (m) | 3.99% | (m) | (m) | (m) |
| 2015-12-31 | $5.25M | $122.52M | (m) | $-6.24M | (m) | 4.29% | (m) | (m) | (m) |
| 2015-09-30 | $5.52M | $113.12M | (m) | $-10.58M | (m) | 4.88% | (m) | (m) | (m) |
| 2015-06-30 | $5.63M | $107.02M | (m) | $-10.47M | (m) | 5.26% | (m) | (m) | (m) |
| 2015-03-31 | $6.00M | $103.54M | (m) | $-15.89M | (m) | 5.80% | (m) | (m) | (m) |
| 2014-12-31 | $5.98M | $102.40M | (m) | $-16.04M | (m) | 5.84% | (m) | (m) | (m) |
| 2014-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | $91.45M | (m) | $-16.84M | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $5.16M | $86.09M | (m) | $-19.97M | (m) | 5.99% | (m) | (m) | (m) |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $5.14M | $63.45M | (m) | $-32.97M | (m) | 8.10% | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Capstone Holding Corp. (CAPS) | United States | $0.004B | -0.15 |
| OLENOX INDUSTRIES INC. (OLOX) | United States | $0.001B | -0.42 |
| BOISE CASCADE Co (BCC) | United States | $2.656B | 25.84 |
| QXO, Inc. (QXO) | United States | $12.730B | -463.75 |